American Journal of Epidemiology Vol. 135, No. 9: 1012-1018
Copyright © 1992 by The Johns Hopkins University School of Hygiene and Public Health
other |
Changing Epidemiology of Hepatitis B in Italy: Public Health Implications
1Laboratorio di Immunologia, Divisione Aerea, Studi, Ricerche e Sperimentazione, Aeronautica Militare Rome, Italy
2Laboratorio di Epidemiologia, Istituto Supenore di Sanita Rome, Italy
3Laboratorio di Virologia, Istituto Supenore di Sanita Rome, Italy
Reprint requests to Dr P Pasquini, Istituto Superiore di Sanita, Laboratorio di Epidemiologia e Biostatistica, Reparto di Epidemiologia Clinica, 299 Viale Regina Elena, Rome, Italy 00161
In Italy, a dramatic decline of hepatitis B infection occurred in recent years as a result of nonmedical and medical factors. The national type-specific surveillance system shows that the age of maximum incidence changed from early childhood, when the risk of becoming a chronic carrier after infection is very high, to late adolescence. Data of several seroepidemiologic studies are consistent with this picture, but could not be compared with previous data on similar age groups. In 1981, a seroepidemiologic study on a national sample of 5, 005 recruits showed a high prevalence of serologic markers of hepatitis B infection among young adults in Italy. In 1990, the authors replicated that original study on a national sample of 4, 993 recruits. The adjusted prevalence of hepatitis B core antibodies among Italian male recruits dropped from 16.8% to 5.8% in 9 years. The authors anticipate a substantial reduction in the rate of production of chronic carriers and the rates of liver cirrhosis and primary liver carcinoma in Italy in the next decades. Vaccination campaigns, especially if combined with nonimmunologic preventive measures, will further reduce the rate of hepatitis B infection in Italy. Am J Epidemiol 1992; 135: 101218
hepatitis B; Preventive medicine; serology
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. M. Bergua, C. Cabrera, H. Banas, M. Marignani, M. C. Cox, G. Delle Fave, L. Milazzo, S. Antinori, and J. L. Dienstag Hepatitis B virus infection. N. Engl. J. Med., January 15, 2009; 360(3): 304 - 305. [Full Text] [PDF] |
||||
